Women’s healthcare company Tia recently closed a $100m Series B funding round that will help to scale its “whole-woman, whole-life” model to over 100k women by 2023.
Just two years after seeing its first patient, Tia now has $132m in total funding for its hybrid care model that operates physical clinics in Los Angeles and New York, as well as virtual care in Phoenix.
- Tia’s hybrid approach combines primary care, mental health, gynecology, and acupuncture to offer women seamless care coordination throughout their entire lives. Tia claims that its proprietary software and care coordination teams can deliver care for 40% less than traditional primary care practices.
- Tia partners with health systems to provide an integrated inpatient/outpatient experience, creating better care continuity around key periods such as pregnancies. These partnerships also allow Tia members to access specialty care not offered at its clinics, like obstetrics.
According to Tia, women control more than 80% of the US’ $3.6t annual healthcare spend, yet female patients have been repeatedly misunderstood and underserved. Investors have taken notice, with Tia’s Series B arriving within a few week’s of Maven Clinic becoming the sector’s first unicorn with over $1b funding.
Industry Impact
Up until recently, women’s healthcare has largely been fragmented by body part or life stage, creating an ineffective model that rarely supports holistic care.
Tia believes its “anti-fragmentation approach” is the solution, driving better outcomes by replacing transactional, condition-based healthcare with relationship-based care that can cater to women throughout their whole lives.
